Bingliang Fang, MD, PhD, Associate Professor, MD Anderson Cancer Center, University of Texas, recently presented the Pathology grand rounds lecture for faculty, residents and staff.

Dr. Fang's lecture topic, "Identification of small compounds targeted to KRas/PKCiota Pathway," is highlighted in the following educational objectives:

• Explain strategies for screening agents for target-based cancer therapy.
• Define methods to characterize molecular mechanisms underlying target-based cancer therapy with small compouds.

For more information, contact Dr. Fang.